Abstract:There is evidence that fatty streaks in arteries can transform into atherosclerotic plaques. Mononuclear cells, including both monocytes and lymphocytes, are among the first cells participating in the development of atherosclerosis of experimental animals. To investigate the roles of different cell types in human atherosclerosis, we enumerated and compared the cellular compositions of normal intima, the transition zone (the area between the normal intima and the core of fatty streaks), fatty streaks, and plaques in young (age 16-30 years) and aged (over 60 years) human specimens using double-staining immunofluorescence with a series of monoclonal and polyclonal antibodies. T lymphocytes, both T helper/inducer (70% of T cells) and T suppressor/cytotoxic (30%) phenotypes, were found in every stage of atherosclerosis, constituting 30 to 40% of total cells in fatty streaks and transition zones of young subjects, and occasionally even in normal intima. Seventy percent of these T cells were HLA-DR positive, which indicated that most of them were activated. Macrophages were most frequent in fatty streaks and around the necrotic core of plaques. Smooth muscle cells, increasing from 5 to 30% with lesion progression, were HLA-DR positive where activated T helper cells occurred in the vicinity. The intracellular presence of the invariant gamma chain confirmed that HLA-DR was actually synthesized by these smooth muscle cells. Endothelial cells were HLA-DR positive above those regions of the lesions where HLA-DR-positive cells had accumulated, but not in normal intima, again suggesting induction of HLA-DR expression by T-cell-derived gamma-interferon. Furthermore, most HLA-DR-positive cells were also identified as HLA-DP and HLA-DQ positive. This aberrant major histocompatibility complex class II antigen expression in smooth muscle and endothelial cells may participate in the perpetuation of the atherogenetic autoimmune reaction.

Expression of Tissue Factor and Interleukin-18 in Human Atherosclerotic Lesions

Clinical significance of serum interleukin-18 (IL-18) and matrix metalloproteinase-(MMP-9) on acute coronary syndrome

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

Relation of Thrombomodulin, TFPI and Plasma Antioxidants in Healthy Individuals and Patients with Coronary Heart Disease.

Tissue factor expression of platelets and leukocytes in patients with acute coronary syndromes]

Tissue factor in atherosclerosis and atherothrombosis

Changes of serum levels of interleukin-18 and tissue factor and its correlation with blood coagulation function in patients with acute cerebral infarction

[The Expression of Chemokine-Like Factor 1 in Human Atherosclerotic Plaques].

Expression of tissue factor, tissue factor pathway inhibitor in the atherosclerotic plaque on femoral artery of New Zealand rabbits

Overexpression of Tissue Factor Induced Atherothrombosis in Apolipoprotein E-/- Mice Via Both Enhanced Plaque Thrombogenicity and Plaque Instability

Research Progress on Interleukin-18,Interleukin-10,Interleukin-18/Interleukin-10 Ratio and the Vulnerability in Coronary Atherosclerosis Plaques

Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation

Correlation between tissue factor pathway inhibitor and coronary artery diseases

Relationship Between Atrial Thrombosis and Plasma Tissue Factor and Tissue Factor Pathway Inhibitor in Patients with Atrial Fibrillation

Interleukin-18 and Acute Coronary Syndrome

Cytokines and atherosclerosis: a comprehensive review of studies in mice

Tissue Factor and Tissue Factor Pathway Inhibitor in Coronary Atherosclerotic Plaque

Immunology of Atherosclerosis: Cellular Composition and Major Histocompatibility Complex Class II Antigen Expression in Aortic Intima, Fatty Streaks, and Atherosclerotic Plaques in Young and Aged Human Specimens

Detection of the Expression of TLR4 in Human Leucocytes of the Atherosclerotic by Flow Cytometry and Its Clinical Significance

Oxhdl_3 and Oxldl Induce the Expression of IL-1β,IL-6,HLA-DR,and CD86 in THP-1 Monocyte-Derived Macrophages

Interleukin 18 Function in Atherosclerosis is Mediated by the Interleukin 18 Receptor and the Na-Cl Co-Transporter